J.-L. Canon

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study

Eric Van Cutsem, Fernando Rivera, Scott Berry et al. · Annals of Oncology · 2009 · 532 citations

Oncology, First-line Bevacizumab, Gastrointestinal Oncology +10

Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung carcinoma before and following chemotherapy: a placebo-controlled randomized phase Ib study.

Véronique D’Hondt, P. Weynants, Yves Humblet et al. · Journal of Clinical Oncology · 1993 · 67 citations

BRCA1 and BRCA2 mutations in Belgian families with a history of breast and/or ovarian cancer

C Sibille-Hoang, Olivier Froment, A Joos de ter Beerst et al. · European Journal of Cancer Prevention · 1998 · 43 citations

Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients

DJ Richel, J.-L. Canon, Thierry Guillaume et al. · Bone Marrow Transplantation · 2000 · 37 citations

Cell-based Drug Delivery, Cell Therapy, Cell Selection +9

Biology of small cell lung cancer: An overview

P. Weynants, Yves Humblet, J.-L. Canon et al. · Lung Cancer · 1991 · 25 citations

Bronchial Neoplasm, Pulmonary Blastoma, Lung Cancer +6